Key result
The 2021 SCAI Think Tank proceedings summarize field-wide discussions on coronary intervention, endovascular medicine, structural heart disease, and congenital heart disease to guide future action.
Why the study?
To present the proceedings from the SCAI 2021 Think Tank to enhance participation, foster broader dialogue, and aid in developing action items across key interventional cardiology areas.
This document summarizes the proceedings of the SCAI 2021 Think Tank, highlighting key discussions and future directions in interventional cardiology, endovascular medicine, structural heart disease, and congenital heart disease.
The Society for Cardiovascular Angiography and Interventions (SCAI) Think Tank is a collaborative venture that brings together interventional cardiologists, administrative partners, and select members of the cardiovascular industry community annually for high‐level field‐wide discussions. The 2021 Think Tank was organized into four parallel sessions reflective of the field of interventional cardiology: (a) coronary intervention, (b) endovascular medicine, (c) structural heart disease, and (d) congenital heart disease. Each session was moderated by a senior content expert and co‐moderated by a member of SCAI's Emerging Leader Mentorship program. This document presents the proceedings to the wider cardiovascular community in order to enhance participation in this discussion, create additional dialog from a broader base, and thereby aid SCAI, the industry community and external stakeholders in developing specific action items to move these areas forward.
No takes yet. Share an insight, caveat, or question.
Naidu et al. (2021) studied interventional cardiology. The 2021 SCAI Think Tank proceedings summarize field-wide discussions on coronary intervention, endovascular medicine, structural heart disease, and congenital heart disease to guide future action.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: